Michael J. Pencina
Michael J. Pencina publishes mostly in Cardiology and Cardiovascular Medicine, Surgery and Endocrinology, Diabetes and Metabolism, on topics such as Lipoproteins and Cardiovascular Health, Diabetes, Cardiovascular Risks, and Lipoproteins and Health Systems, Economic Evaluations, Quality of Life.
- World rank
- #14,075 of 7,710,434 ranked researchers
- Rank in United States
- #4,958 of 1,627,098
- Works
- 515
- Citations
- 64k
- Citations per work
- 125.0
What does Michael J. Pencina research?
Michael J. Pencina's work is mostly in Medicine (45%), Mathematics (7%), Economics, Econometrics and Finance (6%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences23044.6%
- Medicine23044.6%
- Everything else21942.6%
- Physical Sciences346.6%
- Mathematics346.6%
- Social Sciences326.2%
- 1Cardiology and Cardiovascular Medicine20% of their works
- 2Surgery12% of their works
- 3Endocrinology, Diabetes and Metabolism7% of their works
- 4Statistics and Probability7% of their works
- 5Economics and Econometrics6% of their works
- 6Public Health, Environmental and Occupational Health6% of their works
Research topics
- Lipoproteins and Cardiovascular Health
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Systems, Economic Evaluations, Quality of Life
- Cardiovascular Health and Risk Factors
- Statistical Methods in Clinical Trials
- Cardiac Imaging and Diagnostics
- Heart Failure Treatment and Management
- Coronary Interventions and Diagnostics
Which keywords describe Michael J. Pencina's research?
The keywords of their largest research topics: Atherosclerosis, Cardiovascular Disease, Cholesterol-lowering, Statins, Diabetes, Metabolic Syndrome, Cost-effectiveness Analysis and Quality of Life.
- Heart Failure
- Coronary Stents
- Cardiac Imaging
- Adaptive Designs
- Cardiovascular Health
- Quality of Life
- Metabolic Syndrome
- Statins
- Cardiovascular Disease
- Atherosclerosis
- Cholesterol-lowering
- Diabetes
- Cost-effectiveness Analysis
- Epidemiology
- Ideal Cardiovascular Health
- False Discovery Rate
- Coronary Artery Disease
- Guidelines
- Myocardial Revascularization
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 19 words, with their numbers
- Atherosclerosis1062 topics
- Cardiovascular Disease1062 topics
- Cholesterol-lowering951 topic
- Statins951 topic
- Diabetes781 topic
- Metabolic Syndrome781 topic
- Cost-effectiveness Analysis771 topic
- Quality of Life771 topic
- Epidemiology652 topics
- Cardiovascular Health371 topic
- Ideal Cardiovascular Health371 topic
- Adaptive Designs341 topic
- False Discovery Rate341 topic
- Cardiac Imaging301 topic
- Coronary Artery Disease301 topic
- Coronary Stents281 topic
- Guidelines281 topic
- Heart Failure281 topic
- Myocardial Revascularization281 topic
Where does Michael J. Pencina work?
Michael J. Pencina's main affiliation in the publication record is Duke University, United States.
How many publications and citations does Michael J. Pencina have?
OpenAlex counts 515 works and 64,395 citations for Michael J. Pencina, an h-index of 101, ranking #14,075 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Other researchers named Michael J. Pencina
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Michael J. Pencina. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.